Donor-derived CD4+ /CCR7+ T-cell partial selective depletion does not alter acquired anti-infective immunity

Bone Marrow Transplantation

Volumn 49, Issue 5, 2014, Pages 611-615

  Choufi, B ^a,b   Trauet, J ^b,c   Thiant, S ^b,c   Labalette, M ^b,c   Yakoub Agha, I ^b,c  

^a Service d'Hématologie CH Boulogne Sur Mer   (France)

^b UNIV LILLE   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

allogeneic; anti infective immunity; T cell depletion; transplantation

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR7; CYTOMEGALOVIRUS ANTIGEN PP65; GRANULOCYTE COLONY STIMULATING FACTOR; 5-(6)-CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CCR7 PROTEIN, HUMAN; FLUORESCEIN DERIVATIVE; FLUORESCENT DYE; GAMMA INTERFERON; SUCCINIMIDE DERIVATIVE; TRITIUM;

ADAPTIVE IMMUNITY; ADENOVIRUS; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CCR7+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DONOR; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; INFECTION; LYMPHOCYTE CULTURE; MALE; NONHUMAN; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; T CELL DEPLETION; T LYMPHOCYTE; ACUTE DISEASE; BONE MARROW TRANSPLANTATION; CELL PROLIFERATION; CELL SEPARATION; CYTOLOGY; DIAGNOSTIC USE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; IMMUNOLOGY; LYMPHOCYTE DEPLETION; LYMPHOCYTE TRANSFUSION; METABOLISM; PROCEDURES; TRANSPLANTATION;

ACUTE DISEASE; ADULT; BONE MARROW TRANSPLANTATION; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELL SEPARATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FLUORESCEINS; FLUORESCENT DYES; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HUMANS; INTERFERON-GAMMA; LYMPHOCYTE DEPLETION; LYMPHOCYTE TRANSFUSION; MALE; RECEPTORS, CCR7; SUCCINIMIDES; TISSUE DONORS; TRITIUM;

EID: 84900315140     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2014.6     Document Type: Article

References (41)

1. Yakoub-Agha I, De La Salmoniere P, Ribaud P, Sutton L, Wattel E, Kuentz M et al. Allogeneic bone marrow transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia: A long-term study of 70 patients-report of the French society of bone marrow transplantation. J Clin Oncol 2000; 18: 963-971
2. Yakoub-Agha I, Fawaz A, Folliot O, Guillerm G, Quesnel B, Fenaux P et al. Allogeneic bone marrow transplantation in patients with follicular lymphoma: A single center study. Bone Marrow Transplant 2002; 30: 229-234
3. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ et al. Graft-versusleukemia reactions after bone marrow transplantation. Blood 1990; 75: 555-562
4. Appelbaum FR. Graft versus leukemia (GVL) in the therapy of acute lymphoblastic leukemia (ALL). Leukemia 1997; 11(Suppl 4): S15-S17
5. Johnson BD, Becker EE, Truitt RL. Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets. Biol Blood Marrow Transplant 1999; 5: 123-132
6. Ruggeri L, Capanni M, Tosti A, Urbani E, Posati S, Aversa F et al. Innate immunity against hematological malignancies. Cytotherapy 2002; 4: 343-346
7. Talmadge JE. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy. Int Immunopharmacol 2003; 3: 1121-1143
8. Peters C, Matthes-Martin S, Fritsch G, Holter W, Lion T, Witt V et al. Transplantation of highly purified peripheral blood CD34 cells from HLA-mismatched parental donors in 14 children: Evaluation of early monitoring of engraftment. Leukemia 1999; 13: 2070-2078
9. Gajewski J, Gjertson D, Cecka M, Tonai R, Przepiorka D, Hunt L et al. The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantation. Biol Blood Marrow Transplant 1997; 3: 76-82
10. Andre-Schmutz I, Le Deist F, Hacein-Bey S, Hamel Y, Vitetta E, Schindler J et al. Donor T lymphocyte infusion following ex vivo depletion of donor anti-host reactivity by a specific anti-interleukin-2 receptor P55 chain immunotoxin. Transplant Proc 2002; 34: 2927-2928
11. Tiberghien P, Reynolds CW, Keller J, Spence S, Deschaseaux M, Certoux JM et al. Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: An approach for specific in vivo donor T-cell depletion after bone marrow transplantation? Blood 1994; 84: 1333-1341
12. Barrett AJ, Rezvani K, Solomon S, Dickinson AM, Wang XN, Stark G et al. New developments in allotransplant immunology. Hematology (Am Soc Hematol Educ Program) 2003 350-371
13. Tabilio A, Falzetti F, Zei T, De Ioanni M, Bonifacio E, Battelli F et al. Graft engineering for allogeneic haploidentical stem cell transplantation. Blood Cells Mol Dis 2004; 33: 274-280
14. Mohty M, Labopin M, Balere ML, Socie G, Milpied N, Tabrizi R et al. Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: A report from the Societe Francaise De Greffe De Moelle et De Therapie Cellulaire. Leukemia 2010; 24: 1867-1874
15. Bertz H, Spyridonidis A, Wasch R, Grullich C, Egger M, Finke J. A novel GVHDprophylaxis with low-dose alemtuzumab in allogeneic sibling or unrelated donor hematopoetic cell transplantation: The feasibility of deescalation. Biol Blood Marrow Transplant 2009; 15: 1563-1570
16. Yakoub-Agha I, Saule P, Depil S, Micol JB, Grutzmacher C, Boulanger-Villard F et al. A high proportion of donor CD4 T cells expressing the lymph node-homing chemokine receptor CCR7 increases incidence and severity of acute graft-versushost disease in patients undergoing allogeneic stem cell transplantation for hematological malignancy. Leukemia 2006; 20: 1557-1565
17. Anderson BE, McNiff J, Yan J, Doyle H, Mamula M, Shlomchik MJ et al. Memory CD4 T cells do not induce graft-versus-host disease. J Clin Invest 2003; 112: 101-108
18. Chen BJ, Cui X, Sempowski GD, Liu C, Chao NJ. Transfer of allogeneic CD62Lmemory T cells without graft-versus-host disease. Blood 2004; 103: 1534-1541
19. Coghill JM, Carlson MJ, Panoskaltsis-Mortari A, West ML, Burgents JE, Blazar BR et al. Separation of graft-versus-host disease from graft-versus-leukemia responses by targeting CC-chemokine receptor 7 on donor T cells. Blood 2010; 115: 4914-4922
20. Foster AE, Marangolo M, Sartor MM, Alexander SI, Hu M, Bradstock KF et al. Human CD62L- memory T cells are less responsive to alloantigen stimulation than CD62L naive T cells: Potential for adoptive immunotherapy and allodepletion. Blood 2004; 104: 2403-2409
21. Xystrakis E, Bernard I, Dejean AS, Alsaati T, Druet P, Saoudi A. Alloreactive CD4 T lymphocytes responsible for acute and chronic graft-versus-host disease are contained within the CD45RC high but not the CD45RClow subset. Eur J Immunol 2004; 34: 408-417
22. Ahmadzadeh M, Hussain SF, Farber DL. Heterogeneity of the memory CD4 T cell response: Persisting effectors and resting memory T cells. J Immunol 2001; 166: 926-935
23. Cooke KR, Hill GR, Gerbitz A, Kobzik L, Martin TR, Crawford JM et al. Tumor necrosis factor-Alpha neutralization reduces lung injury after experimental allogeneic bone marrow transplantation. Transplantation 2000; 70: 272-279
24. Wysocki CA, Panoskaltsis-Mortari A, Blazar BR, Serody JS. Leukocyte migration and graft-versus-host disease. Blood 2005; 105: 4191-4199
25. Hopken UE, Droese J, Li JP, Joergensen J, Breitfeld D, Zerwes HG et al. The chemokine receptor CCR7 controls lymph node-dependent cytotoxic T cell priming in alloimmune responses. Eur J Immunol 2004; 34: 461-470
26. Chang YJ, Zhao XY, Huo MR, Huang XJ. Expression of CD62L on donor CD4() T cells in allografts: Correlation with graft-versus-host disease after unmanipulated allogeneic blood and marrow transplantation. J Clin Immunol 2009; 29: 696-704
27. Ermann J, Hoffmann P, Edinger M, Dutt S, Blankenberg FG, Higgins JP et al. Only the CD62L subpopulation of CD4CD25 regulatory T cells protects from lethal acute GVHD. Blood 2005; 105: 2220-2226
28. Winn R, Vedder N, Ramamoorthy C, Sharar S, Harlan J. Endothelial and leukocyte adhesion molecules in inflammation and disease. Blood Coagul Fibrinolysis 1998; 9(Suppl 2): S17-S23
29. Sharar SR, Chapman NN, Flaherty LC, Harlan JM, Tedder TF, Winn RK. L-selectin (CD62L) blockade does not impair peritoneal neutrophil emigration or subcutaneous host defense to bacteria in rabbits. J Immunol 1996; 157: 2555-2563
30. Van Leeuwen EM, Van Buul JD, Remmerswaal EB, Hordijk PL, ten Berge IJ, Van Lier RA. Functional re-expression of CCR7 on CMV-specific CD8 T cells upon antigenic stimulation. Int Immunol 2005; 17: 713-719
31. Appay V, Dunbar PR, Callan M, Klenerman P, Gillespie GM, Papagno L et al. Memory CD8 T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002; 8: 379-385
32. Romero P, Zippelius A, Kurth I, Pittet MJ, Touvrey C, Iancu EM et al. Four functionally distinct populations of human effector-memory CD8 T lymphocytes. J Immunol 2007; 178: 4112-4119
33. Sourdive DJ, Murali-Krishna K, Altman JD, Zajac AJ, Whitmire JK, Pannetier C et al. Conserved T cell receptor repertoire in primary and memory CD8 T cell responses to an acute viral infection. J Exp Med 1998; 188: 71-82
34. Reichstetter S, Standifer NE, Geubtner KA, Liu AW, Agar SL, Kwok WW. Cytotoxic herpes simplex type 2-specific, DQ0602-restricted CD4 T-cell clones show alloreactivity to DQ0601. Immunology 2006; 117: 350-357
35. Zorn E, Wang KS, Hochberg EP, Canning C, Alyea EP, Soiffer RJ et al. Infusion of CD4 donor lymphocytes induces the expansion of CD8 donor T cells with cytolytic activity directed against recipient hematopoietic cells. Clin Cancer Res 2002; 8: 2052-2060
36. Weinberg A, Zhang L, Hayward AR. Alloreactive cytotoxic CD4 responses elicited by cytomegalovirus-infected endothelial cells: Role of MHC class I antigens. Viral Immunol 2000; 13: 37-47
37. Harari A, Rizzardi GP, Ellefsen K, Ciuffreda D, Champagne P, Bart PA et al. Analysis of HIV-1- and CMV-specific memory CD4 T-cell responses during primary and chronic infection. Blood 2002; 100: 1381-1387
38. Chen JJ, Huang JC, Shirtliff M, Briscoe E, Ali S, Cesani F et al. CD4 lymphocytes in the blood of HIV() individuals migrate rapidly to lymph nodes and bone marrow: Support for homing theory of CD4 cell depletion. J Leukoc Biol 2002; 72: 271-278
39. Amyes E, Hatton C, Montamat-Sicotte D, Gudgeon N, Rickinson AB, McMichael AJ et al. Characterization of the CD4 T cell response to Epstein-Barr virus during primary and persistent infection. J Exp Med 2003; 198: 903-911
40. Sasson SC, Zaunders JJ, Kelleher AD. The IL-7/IL-7 receptor axis: Understanding its central role in T-cell homeostasis and the challenges facing its utilization as a novel therapy. Curr Drug Targets 2006; 7: 1571-1582
41. Crooks GM, Weinberg K, Mackall C. Immune reconstitution: From stem cells to lymphocytes. Biol Blood Marrow Transplant 2006; 12(Suppl 1): 42-46.